Literature DB >> 24333339

Cross-presentation by human dendritic cell subsets.

Elodie Segura1, Sebastian Amigorena2.   

Abstract

Dendritic cells (DCs) are a heterogeneous population of professional antigen-presenting cells. Several murine DC subsets differ in their phenotype and functional properties, in particular in their ability to cross-present antigens (i.e. to present exogenous antigens on their MHC class I molecules). In humans, distinct DC subpopulations have also been identified but whether some human DC subsets are also specialized at cross-presentation remains debated. Here we review the DC subsets that have been identified in humans and we discuss recent work that addresses their ability to cross-present antigens and their efficiency for CD8(+) T cells activation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD8+ T cells; Cross-presentation; Dendritic cells; Vaccination

Mesh:

Substances:

Year:  2013        PMID: 24333339     DOI: 10.1016/j.imlet.2013.12.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  23 in total

Review 1.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

Review 2.  Dendritic cell-targeted vaccines--hope or hype?

Authors:  Wolfgang Kastenmüller; Kathrin Kastenmüller; Christian Kurts; Robert A Seder
Journal:  Nat Rev Immunol       Date:  2014-09-05       Impact factor: 53.106

Review 3.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

4.  Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation.

Authors:  Marius Döring; Hanna Blees; Nicole Koller; Sabine Tischer-Zimmermann; Mathias Müsken; Frederik Henrich; Jennifer Becker; Elena Grabski; Junxi Wang; Hans Janssen; Werner Zuschratter; Jacques Neefjes; Frank Klawonn; Britta Eiz-Vesper; Robert Tampé; Ulrich Kalinke
Journal:  Blood Adv       Date:  2019-03-26

5.  Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.

Authors:  Yongxiang Yi; Jianbo Han; Yuan Fang; Dongxiao Liu; Zuoyou Wu; Lili Wang; Liang Zhao; Qiang Wei
Journal:  Mol Clin Oncol       Date:  2016-06-10

Review 6.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny.

Authors:  Martin Guilliams; Florent Ginhoux; Claudia Jakubzick; Shalin H Naik; Nobuyuki Onai; Barbara U Schraml; Elodie Segura; Roxane Tussiwand; Simon Yona
Journal:  Nat Rev Immunol       Date:  2014-07-18       Impact factor: 53.106

Review 7.  Targeting human dendritic cells in situ to improve vaccines.

Authors:  Kartik Sehgal; Kavita M Dhodapkar; Madhav V Dhodapkar
Journal:  Immunol Lett       Date:  2014-07-27       Impact factor: 3.685

Review 8.  Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?

Authors:  Gary Reynolds; Muzlifah Haniffa
Journal:  Front Immunol       Date:  2015-06-25       Impact factor: 7.561

Review 9.  Antigen cross-presentation of immune complexes.

Authors:  Barbara Platzer; Madeleine Stout; Edda Fiebiger
Journal:  Front Immunol       Date:  2014-04-01       Impact factor: 7.561

Review 10.  Dendritic cell-targeted vaccines.

Authors:  Lillian Cohn; Lélia Delamarre
Journal:  Front Immunol       Date:  2014-05-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.